Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1987 Jan;25(1):87–90. doi: 10.1128/jcm.25.1.87-90.1987

Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.

A C Lee, B A Crass, M S Bergdoll
PMCID: PMC265830  PMID: 3793877

Abstract

A syringe method was designed to test the effect of tampons on the growth of three toxic shock syndrome-associated strains of Staphylococcus aureus and their in vitro production of toxic shock syndrome toxin 1 (TSST-1) under different conditions. Various amounts of TSST-1 were recovered from different tampons inoculated with these strains. Generally, the addition of 10% porcine blood to the growth medium, incubation in the presence of 5% CO2, or the combination of these two factors resulted in the stimulation of TSST-1 production.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  2. Davis J. P., Chesney P. J., Wand P. J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980 Dec 18;303(25):1429–1435. doi: 10.1056/NEJM198012183032501. [DOI] [PubMed] [Google Scholar]
  3. Kato E., Khan M., Kujovich L., Bergdoll M. S. Production of enterotoxin a. Appl Microbiol. 1966 Nov;14(6):966–972. doi: 10.1128/am.14.6.966-972.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Osterholm M. T., Davis J. P., Gibson R. W., Mandel J. S., Wintermeyer L. A., Helms C. M., Forfang J. C., Rondeau J., Vergeront J. M. Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis. 1982 Apr;145(4):431–440. doi: 10.1093/infdis/145.4.431. [DOI] [PubMed] [Google Scholar]
  5. Quimby F., Nguyen H. T. Animal studies of toxic shock syndrome. Crit Rev Microbiol. 1985;12(1):1–44. doi: 10.3109/10408418509104424. [DOI] [PubMed] [Google Scholar]
  6. Reingold A. L., Dan B. B., Shands K. N., Broome C. V. Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet. 1982 Jan 2;1(8262):1–4. doi: 10.1016/s0140-6736(82)92552-1. [DOI] [PubMed] [Google Scholar]
  7. Reiser R. F., Robbins R. N., Khoe G. P., Bergdoll M. S. Purification and some physicochemical properties of toxic-shock toxin. Biochemistry. 1983 Aug 2;22(16):3907–3912. doi: 10.1021/bi00285a028. [DOI] [PubMed] [Google Scholar]
  8. Schlech W. F., 3rd, Shands K. N., Reingold A. L., Dan B. B., Schmid G. P., Hargrett N. T., Hightower A., Herwaldt L. A., Neill M. A., Band J. D. Risk factors for development of toxic shock syndrome. Association with a tampon brand. JAMA. 1982 Aug 20;248(7):835–839. [PubMed] [Google Scholar]
  9. Schlievert P. M., Blomster D. A., Kelly J. A. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol. 1984 Nov;64(5):666–671. [PubMed] [Google Scholar]
  10. Schlievert P. M., Blomster D. A. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis. 1983 Feb;147(2):236–242. doi: 10.1093/infdis/147.2.236. [DOI] [PubMed] [Google Scholar]
  11. Shands K. N., Schmid G. P., Dan B. B., Blum D., Guidotti R. J., Hargrett N. T., Anderson R. L., Hill D. L., Broome C. V., Band J. D. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980 Dec 18;303(25):1436–1442. doi: 10.1056/NEJM198012183032502. [DOI] [PubMed] [Google Scholar]
  12. Tierno P. M., Jr, Hanna B. A. In vitro amplification of toxic shock syndrome toxin-1 by intravaginal devices. Contraception. 1985 Feb;31(2):185–194. doi: 10.1016/0010-7824(85)90033-2. [DOI] [PubMed] [Google Scholar]
  13. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
  14. Vergeront J. M., Stolz S. J., Crass B. A., Nelson D. B., Davis J. P., Bergdoll M. S. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis. 1983 Oct;148(4):692–698. doi: 10.1093/infdis/148.4.692. [DOI] [PubMed] [Google Scholar]
  15. Wagner G., Bohr L., Wagner P., Petersen L. N. Tampon-induced changes in vaginal oxygen and carbon dioxide tensions. Am J Obstet Gynecol. 1984 Jan 15;148(2):147–150. doi: 10.1016/s0002-9378(84)80165-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES